UBS Group’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,157
| Closed | -$6K | – | 12006 |
|
|
2022
Q3 | $6K | Buy |
+2,157
| New | +$8.17K | ﹤0.01% | 9144 |
|
|
2022
Q1 | – | Sell |
-1,236
| Closed | -$7K | – | 11617 |
|
|
2021
Q4 | $7K | Buy |
+1,236
| New | +$7.91K | ﹤0.01% | 9232 |
|
|
2021
Q2 | – | Sell |
-599
| Closed | -$4K | – | 10408 |
|
|
2021
Q1 | $4K | Buy |
599
+499
| +499% | +$3.63K | ﹤0.01% | 8492 |
|
|
2020
Q4 | $1K | Sell |
100
-255
| -72% | -$1.72K | ﹤0.01% | 8336 |
|
|
2020
Q3 | $2K | Sell |
355
-95
| -21% | -$601 | ﹤0.01% | 7750 |
|
|
2020
Q2 | $3K | Sell |
450
-946
| -68% | -$6.03K | ﹤0.01% | 7602 |
|
|
2020
Q1 | $8K | Buy |
1,396
+647
| +86% | +$4.09K | ﹤0.01% | 7116 |
|
|
2019
Q4 | $5K | Buy |
749
+648
| +642% | +$4.21K | ﹤0.01% | 7628 |
|
|
2019
Q3 | $1K | Buy |
101
+84
| +494% | +$559 | ﹤0.01% | 7930 |
|
|
2019
Q2 | $0 | Hold |
17
| – | – | ﹤0.01% | 8405 |
|
|
2019
Q1 | $0 | Sell |
17
-662
| -97% | -$5.57K | ﹤0.01% | 8479 |
|
|
2018
Q4 | $4K | Sell |
679
-337
| -33% | -$3.4K | ﹤0.01% | 7681 |
|
|
2018
Q3 | $16K | Buy |
1,016
+514
| +102% | +$10.1K | ﹤0.01% | 6950 |
|
|
2018
Q2 | $10K | Buy |
502
+86
| +21% | +$1.49K | ﹤0.01% | 7165 |
|
|
2018
Q1 | $6K | Buy |
416
+387
| +1,334% | +$9.42K | ﹤0.01% | 7190 |
|
|
2017
Q4 | $1K | Sell |
29
-129
| -82% | -$4.51K | ﹤0.01% | 7764 |
|
|
2017
Q3 | $7K | Buy |
158
+129
| +445% | +$17.9K | ﹤0.01% | 7107 |
|
|
2017
Q2 | $4K | Hold |
29
| – | – | ﹤0.01% | 7244 |
|
|
2017
Q1 | $4K | Hold |
29
| – | – | ﹤0.01% | 7118 |
|
|
2016
Q4 | $3K | Hold |
29
| – | – | ﹤0.01% | 7454 |
|
|
2016
Q3 | $4K | Sell |
29
-23
| -44% | -$3.24K | ﹤0.01% | 7231 |
|
|
2016
Q2 | $7K | Buy |
52
+23
| +79% | +$3.1K | ﹤0.01% | 7001 |
|
|
2016
Q1 | $3K | Sell |
29
-139
| -83% | -$15.6K | ﹤0.01% | 7244 |
|
|
2015
Q4 | $23K | Sell |
168
-21
| -11% | -$3.37K | ﹤0.01% | 6620 |
|
|
2015
Q3 | $32K | Buy |
189
+18
| +11% | +$3.78K | ﹤0.01% | 6236 |
|
|
2015
Q2 | $46K | Hold |
171
| – | – | ﹤0.01% | 6073 |
|
|
2015
Q1 | $34K | Buy |
171
+48
| +39% | +$7.79K | ﹤0.01% | 6434 |
|
|
2014
Q4 | $18K | Buy |
+123
| New | +$17.7K | ﹤0.01% | 7825 |
|
Other funds holding FWP
UBS Group's FWP Position: Q4 2022 in Review
UBS Group sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q4 2022, closing a stake of 2,157 shares — an estimated $6K sold.
UBS Group first reported a position in FWP in Q4 2014 and held it in 28 quarters. The position peaked at $46K in Q2 2015. 2 funds tracked by Wall St. Rank hold FWP as of Q4 2022.
- UBS Group reported no remaining Forward Pharma A/S American Depositary Shares position as of Q4 2022 after selling out during the quarter.
- UBS Group sold 2,157 Forward Pharma A/S American Depositary Shares shares in Q4 2022, an estimated $6K.
- UBS Group first reported a position in Forward Pharma A/S American Depositary Shares in Q4 2014 and held it in 28 quarters.
- UBS Group's Forward Pharma A/S American Depositary Shares position peaked at $46K in Q2 2015.
- 2 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q4 2022.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.